PharmaResearch Co., Ltd. (KOSDAQ:214450)

Market Cap	5.04T
Revenue (ttm)	392.31B
Net Income (ttm)	110.97B
Shares Out	10.39M
EPS (ttm)	10,648.93
PE Ratio	45.59
Forward PE	31.53
Dividend	1,100.00 (0.22%)
Ex-Dividend Date	Dec 27, 2024

Volume	79,266
Average Volume	182,044
Open	495,000
Previous Close	499,500
Day's Range	478,000 - 498,500
52-Week Range	121,300 - 534,000
Beta	0.59
RSI	56.33
Earnings Date	Aug 12, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 409
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214450

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.